colircusi gentadexa ótico oftálmico 10 ml
vispring 0,05% col·liri 0,5 ml x 10 unidosis
azulina llorens 0,1% col·liri 5 ml
ليتروزول تيڤع
teva pharmaceutical indust.ltd - letrozole 2.5 mg - tablets - letrozole - letrozole teva tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: letrozole teva is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.
letrozol accord efg 2,5 mg 100 comprim cub pelic
letrozol sandoz 2,5mg 30 comprimidos recubiertos con pelicula efg
letrozol normon efg 2,5 mg 30 comprim cub pelic
letrozol tarbis efg 2,5 mg 30 comprimits recob
letrozol tecnigen 2,5mg 30 comprimidos recubiertos pelicula efg
letrozol stada 2,5mg 30 comprimidos recubiertos con pelicula efg